Probiotics in non-alcoholic fatty liver disease: which and when



Título del documento: Probiotics in non-alcoholic fatty liver disease: which and when
Revista: Annals of hepatology
Base de datos: PERIÓDICA
Número de sistema: 000416105
ISSN: 1665-2681
Autores: 1
2
3
4
1
Instituciones: 1Universita Magna Graecia, Dipartimento di Scienze della Salute, Catanzaro, Calabria. Italia
2Universita La Sapienza, Dipartimento di Pediatria, Roma, Lazio. Italia
3University Hospital Center Touhami Benflis, Department of Internal Medicine, Batna. Argelia
4Consiglio Nazionale delle Ricerche, istituto, Roma, Lazio. Italia
Año:
Volumen: 12
Número: 3
Paginación: 357-363
País: México
Idioma: Inglés
Tipo de documento: Revisión bibliográfica
Enfoque: Analítico
Resumen en inglés Non-alcoholic fatty liver disease (NAFLD) is a common and serious disease. Literature reports the central role of the gut-liver axis in the pathogenesis of NAFLD, and recently suggests that the microbiota is a casual factor of the disease, involved in the interactions between intestinal lumen and liver. Probiotic are commensal bacteria, able to modulate the microbiota with benefits for the health of humans. Several data suggest a range of potentially beneficial medicinal uses for probiotics, in particular in NAFLD patients. However, the species with higher efficacy in this disease are not identified. The present review focuses on the role of gut-liver axis in the pathogenesis, and on the potential therapeutic role of probiotics in the managing of NAFLD
Disciplinas: Medicina
Palabras clave: Gastroenterología,
Terapéutica y rehabilitación,
Microbiota intestinal,
Permeabilidad intestinal,
Probióticos,
Hígado graso no alcohólico,
Patogénesis,
Eje intestino-hígado
Keyword: Gastroenterology,
Therapeutics and rehabilitation,
Intestinal microbiota,
Intestinal permeability,
Probiotics,
Non alcoholic fatty liver,
Pathogenesis,
Gut-liver axis
Texto completo: Texto completo (Ver PDF)